{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T03:04:44Z","timestamp":1788404684077,"version":"build-2803163510"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jtauto.2023.100211","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T12:15:03Z","timestamp":1694002503000},"page":"100211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Paradoxical psoriasis: The flip side of idiopathic psoriasis or an autocephalous reversible drug reaction?"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1199-8526","authenticated-orcid":false,"given":"Jiawei","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7159-879X","authenticated-orcid":false,"given":"Yan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtauto.2023.100211_bib1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/bjd.19169","article-title":"Systematic review examining changes over time and variation in the incidence and prevalence of psoriasis by age and gender","volume":"184","author":"Iskandar","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jtauto.2023.100211_bib2","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1038\/s41598-017-01827-9","article-title":"Exploring the link between cadmium and psoriasis in a nationally representative sample","volume":"7","author":"Liaw","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jtauto.2023.100211_bib3","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/258430","article-title":"Possible triggering effect of influenza vaccination on psoriasis","volume":"2015","author":"Gunes","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jtauto.2023.100211_bib4","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jaad.2017.04.015","article-title":"Smoking and risk of psoriasis: a nationwide cohort study","volume":"77","author":"Lee","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jtauto.2023.100211_bib5","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/bjd.16116","article-title":"Psychological stress and psoriasis: a systematic review and meta-analysis","volume":"178","author":"Snast","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jtauto.2023.100211_bib6","article-title":"Hypertension and risk of psoriasis incidence: an 11-year nationwide population-based cohort study","volume":"13","author":"Kim","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jtauto.2023.100211_bib7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.immuni.2012.04.010","article-title":"The antimicrobial protein REG3A regulates keratinocyte proliferation and differentiation after skin injury","volume":"37","author":"Lai","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.jtauto.2023.100211_bib8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1523-1747.2001.01340.x","article-title":"Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus","volume":"117","author":"Dorschner","year":"2001","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jtauto.2023.100211_bib9","series-title":"Psoriasis and Antimicrobial Peptides","first-page":"21","author":"Takahashi","year":"2020"},{"key":"10.1016\/j.jtauto.2023.100211_bib10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/eji.201344277","article-title":"Cationic antimicrobial peptides in psoriatic skin cooperate to break innate tolerance to self-DNA","volume":"45","author":"Lande","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jtauto.2023.100211_bib11","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature06116","article-title":"Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide","volume":"449","author":"Lande","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jtauto.2023.100211_bib12","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1084\/jem.20172094","article-title":"Foxp3(+) T reg cells control psoriasiform inflammation by restraining an IFN-I-driven CD8(+) T cell response","volume":"215","author":"Stockenhuber","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jtauto.2023.100211_bib13","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1002\/eji.200535579","article-title":"IFN-alpha-conditioned dendritic cells are highly efficient in inducing cross-priming CD8(+) T cells against exogenous viral antigens","volume":"36","author":"Lapenta","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jtauto.2023.100211_bib14","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jaad.2021.06.869","article-title":"Tyrosine kinase 2 and janus KinaseSignal transducer and activator of transcription signaling and inhibition in plaque psoriasis","volume":"86","author":"Krueger","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jtauto.2023.100211_bib15","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.4049\/jimmunol.1202859","article-title":"A restricted role for TYK2 catalytic activity in human cytokine responses revealed by novel TYK2-selective inhibitors","volume":"191","author":"Sohn","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.jtauto.2023.100211_bib16","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1074-7613(00)00054-6","article-title":"Partial impairment of cytokine responses in Tyk2-deficient mice","volume":"13","author":"Karaghiosoff","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.jtauto.2023.100211_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag1974","article-title":"Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity","volume":"8","author":"Dendrou","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jtauto.2023.100211_bib18","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/ni.1698","article-title":"The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo","volume":"10","author":"McGeachy","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jtauto.2023.100211_bib19","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm.3895","article-title":"IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases","volume":"21","author":"Teng","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.jtauto.2023.100211_bib20","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.coi.2007.07.020","article-title":"Th17: the third member of the effector T cell trilogy","volume":"19","author":"Bettelli","year":"2007","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jtauto.2023.100211_bib21","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4049\/jimmunol.1100123","article-title":"Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis","volume":"187","author":"Lin","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.jtauto.2023.100211_bib22","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/jid.2013.526","article-title":"In vivo induction of cutaneous inflammation results in the accumulation of extracellular trap-forming neutrophils expressing RORgammat and IL-17","volume":"134","author":"Keijsers","year":"2014","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jtauto.2023.100211_bib23","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.4049\/jimmunol.1001538","article-title":"Cutting edge: a critical functional role for IL-23 in psoriasis","volume":"185","author":"Tonel","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.jtauto.2023.100211_bib24","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1111\/bjd.15533","article-title":"Interleukin (IL)-17A and IL-22-producing neutrophils in psoriatic skin","volume":"177","author":"Dyring-Andersen","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jtauto.2023.100211_bib25","first-page":"369","article-title":"Invariant NKT cells produce IL-17 through IL-23-dependent and -independent pathways with potential modulation of Th17 response in collagen-induced arthritis","volume":"22","author":"Yoshiga","year":"2008","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.jtauto.2023.100211_bib26","first-page":"21","article-title":"Interleukin-17A and keratinocytes in psoriasis","author":"Furue","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jtauto.2023.100211_bib27","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1600-0625.2010.01134.x","article-title":"Primary human keratinocytes efficiently induce IL-1-dependent IL-17 in CCR6+ T cells","volume":"19","author":"Muhr","year":"2010","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jtauto.2023.100211_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010179","article-title":"Scanning the immunopathogenesis of psoriasis","volume":"19","author":"Chiricozzi","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jtauto.2023.100211_bib29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1620\/tjem.240.47","article-title":"A heterodimeric cytokine, consisting of IL-17a and IL-17F, promotes migration and capillary-like tube formation of human vascular endothelial cells","volume":"240","author":"Numasaki","year":"2016","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.jtauto.2023.100211_bib30","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/bjd.20090","article-title":"Signalling of multiple interleukin (IL)-17 family cytokines via IL-17 receptor A drives psoriasis-related inflammatory pathways","volume":"185","author":"Tollenaere","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jtauto.2023.100211_bib31","first-page":"675","article-title":"Cytokines of the IL-17 family in psoriasis","volume":"18","author":"Lauffer","year":"2020","journal-title":"Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG"},{"key":"10.1016\/j.jtauto.2023.100211_bib32","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.jid.2016.06.009","article-title":"Keratinocyte-derived IL-17e contributes to inflammation in psoriasis","volume":"136","author":"Senra","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jtauto.2023.100211_bib33","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/jid.2008.294","article-title":"Functional characterization of IL-17F as a selective neutrophil attractant in psoriasis","volume":"129","author":"Watanabe","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jtauto.2023.100211_bib34","article-title":"Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis","volume":"8","author":"Singh","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jtauto.2023.100211_bib35","doi-asserted-by":"crossref","first-page":"7257","DOI":"10.4049\/jimmunol.0903719","article-title":"8-methoxypsoralen plus ultraviolet A therapy acts via inhibition of the IL-23\/Th17 axis and induction of Foxp3+ regulatory T cells involving CTLA4 signaling in a psoriasis-like skin disorder","volume":"184","author":"Singh","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.jtauto.2023.100211_bib36","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/intimm\/dxn068","article-title":"TPA induction leads to a Th17-like response in transgenic K14\/VEGF mice: a novel in vivo screening model of psoriasis","volume":"20","author":"Hvid","year":"2008","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jtauto.2023.100211_bib37","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/tpj.2012.53","article-title":"Gene polymorphisms that can predict response to anti-TNF therapy in patients with psoriasis and related autoimmune diseases","volume":"13","author":"Prieto-Perez","year":"2013","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.jtauto.2023.100211_bib38","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/MPG.0b013e31828390ba","article-title":"Infliximab-induced psoriasis and psoriasiform skin lesions in pediatric Crohn disease and a potential association with IL-23 receptor polymorphisms","volume":"56","author":"Sherlock","year":"2013","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jtauto.2023.100211_bib39","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/tpj.2015.53","article-title":"Paradoxical psoriasiform reactions to anti-TNFalpha drugs are associated with genetic polymorphisms in patients with psoriasis","volume":"16","author":"Cabaleiro","year":"2016","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.jtauto.2023.100211_bib40","first-page":"21","article-title":"Paradoxical psoriasis induced by anti-TNFalpha treatment: evaluation of disease-specific clinical and genetic markers","author":"Bucalo","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jtauto.2023.100211_bib41","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.jaad.2020.06.081","article-title":"Family history of psoriasis, psychological stressors, and tobacco use are associated with the development of tumor necrosis factor-alpha inhibitor-induced psoriasis: a case-control study","volume":"83","author":"Ya","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jtauto.2023.100211_bib42","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000027510","article-title":"The incidence of psoriasis among smokers and\/or former smokers inflammatory bowel diseases patients treated with tumor necrosis factor antagonist: a systematic review and meta-analysis","volume":"100","author":"Yang","year":"2021","journal-title":"Medicine"},{"key":"10.1016\/j.jtauto.2023.100211_bib43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/cjp2.147","article-title":"Paradoxical psoriasis induced by TNF-alpha blockade shows immunological features typical of the early phase of psoriasis development","volume":"6","author":"Fania","year":"2020","journal-title":"J Pathol Clin Res"},{"key":"10.1016\/j.jtauto.2023.100211_bib44","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-1-0716-1130-2_11","article-title":"Experimental methods for the immunological characterization of paradoxical psoriasis reactions induced by TNF-alpha biologics","volume":"2248","author":"Morelli","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jtauto.2023.100211_bib45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41467-017-02466-4","article-title":"TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis","volume":"9","author":"Conrad","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jtauto.2023.100211_bib46","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1365-2133.2009.09329.x","article-title":"Cytokine imbalance with increased production of interferon-alpha in psoriasiform eruptions associated with antitumour necrosis factor-alpha treatments","volume":"161","author":"Seneschal","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jtauto.2023.100211_bib47","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1073\/pnas.0408506102","article-title":"J. Banchereau. Cross-regulation of TNF and IFN-alpha in autoimmune diseases","volume":"102","author":"Palucka","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jtauto.2023.100211_bib48","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1191\/096120300674499064","article-title":"Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies","volume":"9","author":"Bengtsson","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.jtauto.2023.100211_bib49","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1126\/science.1064890","article-title":"Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus","volume":"294","author":"Blanco","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jtauto.2023.100211_bib50","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1089\/jir.2011.0071","article-title":"Interferon alpha as a primary pathogenic factor in human lupus","volume":"31","author":"Niewold","year":"2011","journal-title":"J. Interferon Cytokine Res. : the official journal of the International Society for Interferon and Cytokine Research"},{"key":"10.1016\/j.jtauto.2023.100211_bib51","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/gutjnl-2012-302853","article-title":"Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-gamma-expressing Th1 cells and IL-17A\/IL-22-expressing Th17 cells and respond to anti-IL-12\/IL-23 antibody treatment","volume":"63","author":"Tillack","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.jtauto.2023.100211_bib52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/ced.13227","article-title":"T-helper immune phenotype may underlie 'paradoxical' tumour necrosis factor-alpha inhibitor therapy-related psoriasiform dermatitis","volume":"43","author":"Moy","year":"2018","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.jtauto.2023.100211_bib53","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.jid.2019.10.010","article-title":"Enrichment of polyfunctional IL-17-producing T cells in paradoxical psoriasis skin lesions","volume":"140","author":"Moran","year":"2020","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jtauto.2023.100211_bib54","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jaad.2019.08.023","volume":"82","author":"Cohen","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jtauto.2023.100211_bib55","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1084\/jem.20151255","article-title":"Anti-TNF drives regulatory T cell expansion by paradoxically promoting membrane TNF-TNF-RII binding in rheumatoid arthritis","volume":"213","author":"Nguyen","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jtauto.2023.100211_bib56","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10067-013-2352-x","article-title":"The impact of conventional DMARD and biological therapies on CD4+ cell subsets in rheumatoid arthritis: a follow-up study","volume":"33","author":"Szalay","year":"2014","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jtauto.2023.100211_bib57","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s10875-015-0182-0","article-title":"Paradoxical expansion of Th1 and Th17 lymphocytes in rheumatoid arthritis following infliximab treatment: a possible explanation for a lack of clinical response","volume":"35","author":"Talotta","year":"2015","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jtauto.2023.100211_bib58","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1093\/rheumatology\/keq224","article-title":"Increased IL-17 production by peripheral T helper cells after tumour necrosis factor blockade in rheumatoid arthritis is accompanied by inhibition of migration-associated chemokine receptor expression","volume":"49","author":"Aerts","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.jtauto.2023.100211_bib59","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/art.10847","article-title":"Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab","volume":"48","author":"Zou","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2023.100211_bib60","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/cup.14113","article-title":"Expression of microRNA-21 and TIMP-3 in paradoxical psoriasiform reactions during treatment with antitumor necrosis factor agents","volume":"49","author":"Navarro","year":"2022","journal-title":"J. Cutan. Pathol."},{"key":"10.1016\/j.jtauto.2023.100211_bib61","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3899\/jrheum.081074","article-title":"Correlation of CX3CL1 and CX3CR1 levels with response to infliximab therapy in patients with rheumatoid arthritis","volume":"36","author":"Odai","year":"2009","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jtauto.2023.100211_bib62","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.semarthrit.2010.04.003","article-title":"Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesis","volume":"40","author":"Collamer","year":"2010","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2023.100211_bib63","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/eji.200425885","article-title":"CXCR3 is required for migration to dermal inflammation by normal and in vivo activated T cells: differential requirements by CD4 and CD8 memory subsets","volume":"35","author":"Mohan","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jtauto.2023.100211_bib64","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1002\/eji.201343995","article-title":"CCR4 and CXCR3 play different roles in the migration of T cells to inflammation in skin, arthritic joints, and lymph nodes","volume":"44","author":"Al-Banna","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jtauto.2023.100211_bib65","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3389\/fimmu.2019.00887","article-title":"Restored and enhanced memory T cell immunity in rheumatoid arthritis after TNFalpha blocker treatment","volume":"10","author":"Khanniche","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2023.100211_bib66","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/ard.62.9.829","article-title":"Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease?","volume":"62","author":"Baeten","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2023.100211_bib67","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.jaad.2018.12.018","article-title":"TNF-alpha inhibitor-induced psoriasis: a decade of experience at the Cleveland Clinic","volume":"83","author":"Mazloom","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jtauto.2023.100211_bib68","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jaad.2016.08.012","article-title":"Tumor necrosis factor-alpha inhibitor-induced psoriasis: systematic review of clinical features, histopathological findings, and management experience","volume":"76","author":"Brown","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jtauto.2023.100211_bib69","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/bjd.20980","article-title":"Paradoxical psoriasis after exposure to tumor necrosis factor inhibitors in children-A retrospective cohort study","volume":"186","author":"Kodama","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jtauto.2023.100211_bib70","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14225","article-title":"Tumor necrosis factors-alpha inhibition-induced paradoxical psoriasis: a case series and literature review","volume":"33","author":"Lian","year":"2020","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.jtauto.2023.100211_bib71","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/ced.14500","article-title":"Paradoxical psoriasis caused by tumour necrosis factor inhibitor therapy","volume":"46","author":"Boggs","year":"2021","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.jtauto.2023.100211_bib72","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jaad.2020.12.010","article-title":"Paradoxical eruptions to targeted therapies in dermatology: a systematic review and analysis","volume":"86","author":"Murphy","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jtauto.2023.100211_bib73","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jaad.2020.01.006","article-title":"Histologic comparison of tumor necrosis factor-alpha inhibitor-induced psoriasis and psoriasis vulgaris","volume":"83","author":"Hu","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jtauto.2023.100211_bib74","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.crohns.2012.08.007","article-title":"Induction or exacerbation of psoriatic lesions during anti-TNF-alpha therapy for inflammatory bowel disease: a systematic literature review based on 222 cases","volume":"7","author":"Denadai","year":"2013","journal-title":"Journal of Crohn's & colitis"},{"key":"10.1016\/j.jtauto.2023.100211_bib75","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13132","article-title":"Successful management of infliximab-induced generalized pustular psoriasis without therapy discontinuation in a patient with psoriatic arthritis","volume":"32","author":"Zheng","year":"2019","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.jtauto.2023.100211_bib76","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/039463200902200126","article-title":"Efficacy of cyclosporine in the treatment of a case of infliximab-induced erythrodermic psoriasis","volume":"22","author":"Bruzzese","year":"2009","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.jtauto.2023.100211_bib77","doi-asserted-by":"crossref","first-page":"328","DOI":"10.36849\/JDD.2020.2106","article-title":"Tumor necrosis factor inhibitor-induced psoriasis in a pediatric crohn's disease patient successfully treated with ustekinumab","volume":"19","author":"Bonomo","year":"2020","journal-title":"J. Drugs Dermatol. JDD : J. Drugs Dermatol. JDD"},{"key":"10.1016\/j.jtauto.2023.100211_bib78","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13791","article-title":"Adalimumab-induced scalp psoriasis with severe alopecia as a paradoxical effect in a patient with Crohn's disease successfully treated with ustekinumab","volume":"33","author":"Koumaki","year":"2020","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.jtauto.2023.100211_bib79","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.12998\/wjcc.v9.i15.3655","article-title":"Recalcitrant paradoxical pustular psoriasis induced by infliximab: two case reports","volume":"9","author":"Xia","year":"2021","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.jtauto.2023.100211_bib80","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3794","article-title":"DNA copy number variation associated with anti-tumour necrosis factor drug response and paradoxical psoriasiform reactions in patients with moderate-to-severe psoriasis","volume":"101","author":"Sanz-Garcia","year":"2021","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.jtauto.2023.100211_bib81","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1111\/1346-8138.16103","article-title":"Clinical background of patients with psoriasiform skin lesions due to tumor necrosis factor antagonist administration at a single center","volume":"48","author":"Mori","year":"2021","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jtauto.2023.100211_bib82","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/ijd.14072","article-title":"Clinical management of Anti-TNF-alpha-induced psoriasis or psoriasiform lesions in inflammatory bowel disease patients: a systematic review","volume":"57","author":"Melo","year":"2018","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.jtauto.2023.100211_bib83","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/2475530318810851","article-title":"TNF inhibitor-induced psoriasis: proposed algorithm for treatment and management","volume":"4","author":"Li","year":"2019","journal-title":"J. Psoriasis Psoriatic Arthritis"},{"key":"10.1016\/j.jtauto.2023.100211_bib84","series-title":"Paradoxical Reactions to Biologicals in Chronic Inflammatory Systemic Diseases","author":"Kremenevski","year":"2022"},{"key":"10.1016\/j.jtauto.2023.100211_bib85","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15084","article-title":"Paradoxical psoriasis induced by anti-TNF-alpha successfully treated with brodalumab","volume":"34","author":"Cortonesi","year":"2021","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.jtauto.2023.100211_bib86","doi-asserted-by":"crossref","first-page":"199","DOI":"10.36849\/JDD.2020.4662","article-title":"Successful management of anti-TNF-induced psoriasis despite continuation of therapy in a pyoderma gangrenosum patient","volume":"19","author":"Toussi","year":"2020","journal-title":"J. Drugs Dermatol. JDD : J. Drugs Dermatol. JDD"},{"key":"10.1016\/j.jtauto.2023.100211_bib87","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1084\/jem.20101102","article-title":"Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons","volume":"207","author":"Gregorio","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jtauto.2023.100211_bib88","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.4049\/jimmunol.0901706","article-title":"Human plasmacytoid dendritic cells support Th17 cell effector function in response to TLR7 ligation","volume":"184","author":"Yu","year":"2010","journal-title":"J. Immunol."}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909023000242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909023000242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:37:48Z","timestamp":1762904268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589909023000242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":88,"alternative-id":["S2589909023000242"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2023.100211","relation":{},"ISSN":["2589-9090"],"issn-type":[{"value":"2589-9090","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paradoxical psoriasis: The flip side of idiopathic psoriasis or an autocephalous reversible drug reaction?","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2023.100211","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100211"}}